Specific cardiomyopathy in lupus patients: Report of three cases

Joint Bone Spine

Volumn 71, Issue 1, 2004, Pages 66-69

  Gottenberg, Jacques Eric ^a   Roux, Sophie ^a   Assayag, Patrick ^a   Clerc, Didier ^a   Mariette, Xavier ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Cardiomyopathy; Immunosuppressor; Lupus

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; WARFARIN;

ADOLESCENT; ADULT; ANAMNESIS; CARDIOMYOPATHY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MALE; MYOCARDITIS; POLYARTHRITIS; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0842310340     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(03)00101-5     Document Type: Article

References (11)

1. Moder K.G., Miller T.D., Tazelaar H.D. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc. 74:1999;275-284.
2. Fairfax M.J., Osborn T.G., Williams G.A., Tsai C.C., Moore T.L. Endomyocardial biopsy in patients with systemic lupus erythematosus. J Rheumatol. 15:1988;593-596.
3. Vaarala O., Manttari M., Manninen V., Tenkanen L., Puurunen M., Aho K. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation. 91:1995;23-27.
4. Asherson R.A., Cervera R. Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation. 84-92:1991;920-922.
5. Naarendorp M., Kerr L.D., Khan A.S., Ornstein M.H. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol. 26:1999;2257-2260.
6. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. NEJM. 333:1995;269-275.
7. Borenstein D.G., Fye W.B., Arnett F.C., Stevens M.B. The myocarditis of systemic lupus erythematosus. Association with myositis. Ann Intern M. 89:(1):1978;619-624.
8. Estes M.L., Ewing-Wilson D., Chou S.M., et al. Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J M. 82:1987;447-455.
9. Bulkley B.H., Roberts W.C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy; a study of 36 necropsy patients. Am J M. 58:1975;243-264.
10. Petri M., Perez-Gutthann S., Spence D. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J M. 93:1992;513-519.
11. Morguet A.J., Sandrock D., Stille-Siegener M., Figulla H.R. Indium-111-antimyosin Fab imaging to demonstrate myocardial involvement in systemic lupus erythematosus. J Nucl M. 36:1995;1432-1435.